A PYMNTS Company

US: DOJ may not challenge Aetna-CVS deal

By  |  July 15, 2018

Shares of CVS Health Corp and Aetna Inc jumped Thursday, July 12, on reports that the US Department of Justice (DOJ) will not challenge the US$69 billion purchase of the Hartford health insurer.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Bloomberg reported the DOJ’s decision, citing publication Reorg Research.

    Shares of Aetna closed at $191.08, up less than 2%, after climbing nearly 2.5% earlier in the day. CVS ended the day at US$67.99, up 1% after jumping more than 4% at one point during the day.

    The federal government blocked Aetna last year from buying Humana in Louisville, in a US$37 billion deal. The DOJ said the acquisition was anti-consumer and a federal judge agreed, striking down the deal.

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.